Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...
Rheumatoid arthritis patients often don't notice disease flares until symptoms have already worsened substantially. As joint ...
A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 inhibitor in China has hit its primary endpoint, boosting ...
Augurex CEO Neil Klompas describes why it is difficult for biomarkers to diagnose rheumatoid arthritis in some cases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback